JRSS (JRSIS Health Care) YoY EBITDA Growth: 116.67% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is JRSIS Health Care YoY EBITDA Growth?

JRSIS Health Care JRSS YoY EBITDA Growth is 116.67% as of Mar. 2025.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. JRSIS Health Care's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 116.67%.

JRSIS Health Care's EBITDA per Share for the three months ended in Mar. 2025 was $0.00.

JRSIS Health Care YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for JRSIS Health Care's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JRSIS Health Care YoY EBITDA Growth Chart

JRSIS Health Care Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.97 -101.13 -64.29 82.61 -231.25

JRSIS Health Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -238.46 16.67 -387.50 90.00 116.67

JRSIS Health Care YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

JRSIS Health Care's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.053--0.016)/ | -0.016 |
=-231.25 %

JRSIS Health Care's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.003--0.018)/ | -0.018 |
=116.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 116.67% mean?
JRSIS Health Care (JRSS) has a YoY EBITDA Growth of 116.67% as of Mar. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for JRSIS Health Care and its competitors.
Is JRSIS Health Care's YoY EBITDA Growth too high?
JRSIS Health Care's current YoY EBITDA Growth is 116.67%.
How does JRSIS Health Care's YoY EBITDA Growth compare to NVVE and FTEL?
JRSIS Health Care's YoY EBITDA Growth of 116.67% can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Retail - Cyclical company?
A good YoY EBITDA Growth depends on the Retail - Cyclical industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for JRSIS Health Care and its competitors. JRSIS Health Care's current YoY EBITDA Growth is 116.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JRSIS Health Care stock overvalued right now?
JRSIS Health Care (JRSS) has a current YoY EBITDA Growth of 116.67%. The current YoY EBITDA Growth is 116.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For JRSIS Health Care (JRSS), the current YoY EBITDA Growth is 116.67% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JRSIS Health Care Business Description

Address Yongzhou Economic and Technology Development Zone, Building 2, Youth Innovation and Entrepreneurship Park, Xiaoxiang Science and Technology Innovation Center, Hunan Province, Yongzhou, CHN, 425000
JRSIS Health Care Corp, through its subsidiaries, is mainly engaged in providing charging services to electric vehicles incorporated in Zhongshan City of Guangdong, China.